메뉴 건너뛰기




Volumn 255, Issue 2, 2008, Pages 280-287

Contribution of relapses to disability in multiple sclerosis

Author keywords

Disability; Multiple sclerosis; Prognosis; Relapse

Indexed keywords

STEROID;

EID: 40149103606     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0743-8     Document Type: Article
Times cited : (119)

References (31)
  • 1
    • 0023936377 scopus 로고
    • Amato MP, Fratiglioni L, Groppi C, Siracusa G, Amaducci L (1988) Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. Arch Neurol 45:746-748
    • (1988) Arch Neurol , vol.45 , pp. 746
    • Amato1
  • 2
    • 0034986367 scopus 로고    scopus 로고
    • Bethoux F, Miller DM, Kinkel RP (2001) Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life. Mult Scler 7:137-142
    • (2001) Mult Scler , vol.7 , pp. 137
    • Bethoux1
  • 3
    • 0034992601 scopus 로고    scopus 로고
    • Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14:271-278
    • (2001) Curr Opin Neurol , vol.14 , pp. 271
    • Bjartmar1
  • 4
    • 0025817469 scopus 로고
    • Bornstein MB, Miller A, Slagle S, Weitzman M, Drexler E, Keilson M, Spada V, Weiss W, Appel S, Rolak L, et al. (1991) A placebo-controlled, double-blind, randomized, two- center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology 41:533-539
    • (1991) Neurology , vol.41 , pp. 533
    • Bornstein1
  • 5
    • 0037029424 scopus 로고    scopus 로고
    • Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221-1231
    • (2002) Lancet , vol.359 , pp. 1221
    • Compston1
  • 6
    • 33644628396 scopus 로고    scopus 로고
    • Confavreux C, Vukusic S (2006) Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment. Clin Neurol Neurosurg 108:327-332
    • (2006) Clin Neurol Neurosurg , vol.108 , pp. 327
    • Confavreux1
  • 7
    • 0037379402 scopus 로고    scopus 로고
    • Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126:770-782
    • (2003) Brain , vol.126 , pp. 770
    • Confavreux1
  • 8
    • 0022633684 scopus 로고
    • Durelli L, Cocito D, Riccio A, Barile C, Bergamasco B, Baggio GF, Perla F, Delsedime M, Gusmaroli G, Bergamini L (1986) High-dose intravenous methyl prednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations. Neurology 36:238-243
    • (1986) Neurology , vol.36 , pp. 238
    • Durelli1
  • 9
    • 0037983828 scopus 로고    scopus 로고
    • Eriksson M, Andersen O, Runmarker B (2003) Long-term follow up of patients with clinically isolated syndromes, relapsing- remitting and secondary progressive multiple sclerosis. Mult Scler 9:260-274
    • (2003) Mult Scler , vol.9 , pp. 260
    • Eriksson1
  • 10
    • 0014902840 scopus 로고
    • Fog T, Linnemann F (1970) The course of multiple sclerosis in 73 cases with computer-designed curves. Acta Neurol Scand 47(Suppl):3-175
    • (1970) Acta Neurol Scand , vol.47 , pp. 3
    • Fog1
  • 11
    • 0027418515 scopus 로고
    • IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655-661
    • (1993) Neurology , vol.43 , pp. 655
    • Ifnb1
  • 12
    • 0034727059 scopus 로고    scopus 로고
    • Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 343:898-904
    • (2000) N Engl J Med , vol.343 , pp. 898
    • Jacobs1
  • 13
    • 0031750982 scopus 로고    scopus 로고
    • Kantarci O, Siva A, Eraksoy M, Karabudak R, Sutlas N, Agaoglu J, Turan F, Ozmenoglu M, Togrul E, Demirkiran M (1998) Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology 51:765-772
    • (1998) Neurology , vol.51 , pp. 765
    • Kantarci1
  • 14
    • 0017662649 scopus 로고
    • Kurtzke JF, Beebe GW, Nagler B, Kurland LT, Auth TL (1977) Studies on the natural history of multiple sclerosis - 8. Early prognostic features of the later course of the illness. J Chronic Dis 30:819-830
    • (1977) J Chronic Dis , vol.30 , pp. 819
    • Kurtzke1
  • 15
    • 0344738667 scopus 로고    scopus 로고
    • Lublin FD, Baier M, Cutter G (2003) Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 61:1528-1532
    • (2003) Neurology , vol.61 , pp. 1528
    • Lublin1
  • 17
    • 8044242916 scopus 로고    scopus 로고
    • Millefiorini E, Gasperini C, Pozzilli C, D'Andrea F, Bastianello S, Trojano M, Morino S, Morra VB, Bozzao A, Calo A, Bernini ML, Gambi D, Prencipe M (1997) Randomized placebo-controlled trial of mitoxantrone in relapsing- remitting multiple sclerosis: 24- month clinical and MRI outcome. J Neurol 244:153-159
    • (1997) J Neurol , vol.244 , pp. 153
    • Millefiorini1
  • 18
    • 4344571037 scopus 로고    scopus 로고
    • Nos C, Sastre-Garriga J, Borras C, Rio J, Tintore M, Montalban X (2004) Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis. Mult Scler 10:413-416
    • (2004) Mult Scler , vol.10 , pp. 413
    • Nos1
  • 19
    • 0025314243 scopus 로고
    • Noseworthy JH, Vandervoort MK, Wong CJ, Ebers GC (1990) Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group. Neurology 40:971-975
    • (1990) Neurology , vol.40 , pp. 971
    • Noseworthy1
  • 20
    • 2942589194 scopus 로고    scopus 로고
    • O'Connor PW, Goodman A, Willmer- Hulme AJ, Libonati MA, Metz L, Murray RS, Sheremata WA, Vollmer TL, Stone LA (2004) Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects. Neurology 62:2038-2043
    • (2004) Neurology , vol.62 , pp. 2038
    • O'Connor1
  • 21
    • 0842305095 scopus 로고    scopus 로고
    • Ozakbas S, Cagiran I, Ormeci B, Idiman E (2004) Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. J Neurol Sci 218:3-7
    • (2004) J Neurol Sci , vol.218 , pp. 3
    • Ozakbas1
  • 22
    • 0014458409 scopus 로고
    • Panelius M (1969) Studies on epidemiological, clinical and etiological aspects of multiple sclerosis. Acta Neurol Scand:Suppl 39:31-82
    • (1969) Acta Neurol Scand:Suppl , vol.39 , pp. 31
    • Panelius1
  • 23
    • 0036196863 scopus 로고    scopus 로고
    • Patzold T, Schwengelbeck M, Ossege LM, Malin JP, Sindern E (2002) Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Acta Neurol Scand 105:164-168
    • (2002) Acta Neurol Scand , vol.105 , pp. 164
    • Patzold1
  • 24
    • 0019967543 scopus 로고
    • Patzold U, Pocklington PR (1982) Course of multiple sclerosis. First results of a prospective study carried out of 102 MS patients from 1976-1980. Acta Neurol Scand 65:248-266
    • (1982) Acta Neurol Scand , vol.65 , pp. 248
    • Patzold1
  • 25
    • 0020686503 scopus 로고
    • Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
    • (1983) Ann Neurol , vol.13 , pp. 227
    • Poser1
  • 26
    • 0345601517 scopus 로고    scopus 로고
    • PRISMS Study Group (1998) Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 352:1498-1504
    • (1998) Lancet , vol.352 , pp. 1498
    • Prisms1
  • 27
    • 76549217481 scopus 로고
    • Schumacker GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, Nagler B, Sibley WA, Tourtellotte WW, Willmon TL (1965) Problems of experimental trials of therapy in multiple sclerosis: report by the Panel On the Evaluation of Experimental Trials of Therapy in Multiple Sclerosis. Ann N Y Acad Sci 122:552-568
    • (1965) Ann N Y Acad Sci , vol.122 , pp. 552
    • Schumacker1
  • 28
    • 0033615464 scopus 로고    scopus 로고
    • Smith KJ, McDonald WI (1999) The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 354:1649-1673
    • (1999) Philos Trans R Soc Lond B Biol Sci , vol.354 , pp. 1649
    • Smith1
  • 29
    • 33751180140 scopus 로고    scopus 로고
    • Waxman SG (2006) Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat Rev Neurosci 7:932-941
    • (2006) Nat Rev Neurosci , vol.7 , pp. 932
    • Waxman1
  • 30
    • 0024796845 scopus 로고
    • Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 112(Pt 6):1419-1428
    • (1989) Brain , vol.112 , pp. 1419
    • Weinshenker1
  • 31
    • 33748681140 scopus 로고    scopus 로고
    • West T, Wyatt M, High A, Bostrom A, Waubant E (2006) Are initial demyelinating event recovery and time to second event under differential control? Neurology 67:809-813
    • (2006) Neurology , vol.67 , pp. 809
    • West1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.